Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content and navigation. This indicates access to the record is blocked, preventing viewing of the study details.
    Difference
    18%
    Check dated 2026-09-20T20:09:35.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract years 2018 and 2023 in the funding information, and the revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:25:24.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays an error screen instead of the study record. This prevents access to the study details and related information on NCT03815058.
    Difference
    17%
    Check dated 2026-08-09T12:00:30.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, indicating a backend update to the ClinicalTrials.gov page. This update appears to be a software version change rather than a modification to study details.
    Difference
    0.0%
    Check dated 2026-07-25T23:59:06.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 was added and the previous v3.6.2 tag was removed from the page, updating the revision history.
    Difference
    0.0%
    Check dated 2026-07-04T13:03:42.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a minor behind-the-scenes update to the page version.
    Difference
    0.0%
    Check dated 2026-06-27T06:41:30.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.